J. Hughes

T. Maruyama, D. Milich, J. Jones, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly.

F. Schödel, D. Milich, D. Peterson, 1993, The Journal of biological chemistry.

Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.

A. Moriarty, G. Bitter, D. Milich, 1990, Journal of immunology.

Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity.

G. B. Thornton, K. Langley, D. Milich, 1990, Journal of immunology.

Interaction of the Hepatitis B Core Antigen and the Innate Immune System1

M. Sallberg, L. Frelin, Byung O. Lee, 2009, The Journal of Immunology.

Hepatitis B virus core particles as a vaccine carrier moiety.

F. Schödel, D. Milich, D. Peterson, 1994, International reviews of immunology.

Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences

F. Chisari, A. Raney, J. Sorge, 1987, Journal of virology.

A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.

F. Schödel, D. Milich, D. Peterson, 1993, Vaccine.

Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.

A. Moriarty, G. B. Thornton, D. Milich, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.

R. Wirtz, F. Schödel, D. Milich, 1996, Journal of biotechnology.

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

R. Wirtz, F. Schödel, J. Sadoff, 1994, The Journal of experimental medicine.

Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides.

R. Houghten, G. B. Thornton, A. Raney, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.

M. Sällberg, D. Milich, T. Phillips, 2001, Vaccine.

Combinatorial Approach to Hepadnavirus-Like Particle Vaccine Design

M. Sallberg, J. Billaud, D. Milich, 2005, Journal of Virology.

Hybrid Hepatitis B Virus Core/Pre-S Particles: Position Effects on Immunogenicity of Heterologous Epitopes and Expression in Avirulent Salmonellae for Oral Vaccination

F. Schödel, D. Milich, D. Peterson, 1993 .

Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model.

P. Linsley, D. Milich, J. Jones, 1994, Journal of immunology.

Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms.

T. Maruyama, M. Sallberg, Byung O. Lee, 2007, Vaccine.

Immunity to Malaria Elicited by Hybrid Hepatitis B Virus Core Particles Carrying Circumsporozoite Protein Epitopes By Florian Sch6del,* Robert Wirtz,* Darrell Peterson,~

D. Milich, J. Hughes, Jerald Sadoff, 1994 .

Expression ofHepatitis B VirusSurface andCoreAntigens: Influences ofPre-SandPrecore Sequencest

F. Chisari, A. Raney, D. Milich, 1987 .